The main GLP-1 drug risks include developing gallstones, pancreatitis, or more severe gastrointestinal problems, such as a bowel obstruction or gastroparesis (in which the muscles in the stomach dont move food properly for digestion), although these are rare
The bigger question is not how soon theyll be prescribed, but how responsibly, Ms
Iwai S, Kaji K, Nishimura N, Kubo T, Tomooka F, Shibamoto A, et al
Although its exact mechanism of action is unclear, semaglutide GLP-1 is believed to cause weight loss through some specific functions
You're deciding which platform has the structure to still be serving patients at the same terms when you're six months into a titration protocol